Related Experiment Video
Updated: Apr 29, 2026
04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
2.8K
The pathophysiology of thyroid eye disease
Shannon J C Shan1, Raymond S Douglas
1Wilmer Eye Institute (SJCS), The Johns Hopkins University School of Medicine, Baltimore, Maryland; and Kellogg Eye Center (RSD), University of Michigan, Ann Arbor, Michigan.
Summary
Thyroid eye disease (TED) involves orbital fibroblasts (OFs) activated by autoimmune processes, leading to tissue changes. Understanding these cellular interactions is key to managing this complex condition.
Area of Science:
- Ophthalmology
- Immunology
- Endocrinology
Background:
- Thyroid eye disease (TED) pathophysiology is complex and not fully understood.
- Orbital fibroblasts (OFs) are implicated as key effector cells in TED's soft tissue enlargement.
- TED involves autoimmune reactions targeting orbital tissues.
Purpose of the Study:
- To elucidate the cellular and molecular mechanisms underlying thyroid eye disease.
- To identify the role of orbital fibroblasts and fibrocytes in TED pathogenesis.
- To understand the interplay between autoantigens, autoantibodies, and immune cells in TED.
Main Methods:
- Review of current literature on TED pathophysiology.
- Analysis of the role of orbital fibroblasts and their activation pathways.
- Investigation of fibrocytic infiltration and immune cell involvement in the TED orbit.
Main Results:
- Orbital fibroblasts express pathogenic autoantigens like TSHR and IGF-1R.
- Activation of OFs by autoantibodies leads to increased hyaluronan and cytokine production.
- Fibrocytes may contribute to orbital expansion and inflammation in TED.
- Lymphocytes and cytokines play a crucial role in the autoimmune process of TED.
Conclusions:
- Orbital fibroblasts are central to TED pathogenesis, mediating tissue changes through activation and differentiation.
- Infiltrating fibrocytes represent a significant cellular component contributing to orbital inflammation and expansion.
- The autoimmune cascade involving lymphocytes, cytokines, and autoantigens drives TED progression.
Related Concept Videos
01:28Graves' Disease I: Introduction
23
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
23
01:24Graves Disease II: Pathophysiology
26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
01:23Hypothyroidism II: Pathophysiology
26
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
26
01:27Hyperthyroidism II: Pathophysiology
27
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
27
01:25Hyperthyroidism I: Introduction
30
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
01:20Synthesis and Regulation of Thyroid Hormones
7.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K